Skip to content

Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP

Evaluation of Sleep Schedules Modifications in Moderate to Severe Sleep Apnea Patients Treated by nCPAP

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01355419
Enrollment
150
Registered
2011-05-18
Start date
2010-08-31
Completion date
2014-08-31
Last updated
2015-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive sleep apnea, CPAP, actigraphy, sleep, physical activity

Brief summary

In Obstructive sleep apnea (OSA) patients, sleep is disrupted and sleep quality is very poor. The investigators can suppose that with continuous positive airway pressure (CPAP) therapy, there is an improvement in sleep quality, such that patients need less sleep to be fit. Sleep schedules on mid term periods in OSA patients under CPAP therapy has not been studied. The investigators have planned to study sleep schemes before and after CPAP therapy in moderate to severe sleepy OSA patients.

Detailed description

In Obstructive sleep apnea (OSA) patients, sleep is disrupted and sleep quality is very poor. The investigators can suppose that with CPAP therapy, there is an improvement in sleep quality, such that patients need less sleep to be fit. Patients often report this fact, but it has not been objectivated. Sleep schedules on mid term periods in OSA patients under CPAP therapy has not been studied. The investigators have planned to study sleep schemes before and after CPAP therapy in moderate to severe sleepy OSA patients. Sleep schemes and physical activity will be studied with actigraphy. Study Design : prospective study. Number of patients supposed to be studied: 190 Methods: Patients Ø OSA patients assessed by polysomnography, showing apnea-hypopnea index \> 20, and Epworth Sleepiness Scale Score(ESS) \>10 Ø Indication of CPAP therapy Initial Evaluation : * Phase 1 * ESS * BMI * Questionnaire : Nottingham health profile * Comorbidities -medical therapy * Smoking/alcohol Consumption * Then, we give an Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days * Phase 2 * Actigraphy report * Start of CPAP therapy(pressure adjusted according to autoCPAP device report after minimum one night) Second Evaluation, after 3 months under CPAP: * Phase 1 § ESS * BMI * CPAP observance report to calculate mean use/day * Questionnaire : Nottingham health profile * Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days * Phase 2: after 1 week under CPAP and actigraphy * Actigraphy report * CPAP observance report * CPAP Tolerance Questionnaire Ø

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire Saint Pierre
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Moderate to severe OSA * sleepy (sleepiness assessed by Epworth Sleepiness Scale) * indication for CPAP therapy

Exclusion criteria

* narcolepsy * age \< 18 * non sleepy Moderate to severe OSA * no CPAP treatment required

Design outcomes

Primary

MeasureTime frameDescription
Change in Total Sleep Time Before and After CPAP Therapy in Obstructive Sleep Apnea Patientsbaseline and at 3 monthschange in Total sleep time before and after CPAP therapy in obstructive sleep apnea patients, assessed by actigraphy

Secondary

MeasureTime frameDescription
Change in Physical Activity (Number of Steps/Day)Before and After CPAP Therapy in OSA Patientsbaseline and at 3 monthsChange in Physical activity (number of steps/day)before and after CPAP therapy in OSA patientsevaluated by actigraphy

Countries

Belgium

Participant flow

Participants by arm

ArmCount
Obstructive Sleep Apnea, CPAP
moderate to severe obstructive sleep apnea requiring CPAP therapy
150
Total150

Baseline characteristics

CharacteristicObstructive Sleep Apnea, CPAP
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
150 Participants
Age, Continuous51 years
STANDARD_DEVIATION 10
Region of Enrollment
Belgium
150 participants
Sex: Female, Male
Female
60 Participants
Sex: Female, Male
Male
90 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 142
serious
Total, serious adverse events
0 / 142

Outcome results

Primary

Change in Total Sleep Time Before and After CPAP Therapy in Obstructive Sleep Apnea Patients

change in Total sleep time before and after CPAP therapy in obstructive sleep apnea patients, assessed by actigraphy

Time frame: baseline and at 3 months

ArmMeasureValue (MEAN)Dispersion
Obstructive Sleep Apnea, CPAPChange in Total Sleep Time Before and After CPAP Therapy in Obstructive Sleep Apnea Patients29 minutesStandard Deviation 17
Comparison: A power analysis conducted prior to the study predicted that a sample of 144 patients would provide an 80% power to detect a mean difference in sleep time of 40 minutes, assuming a standard deviation of 85 minutes and using a two-sided significance level of 5%.p-value: <0.05t-test, 2 sided
Secondary

Change in Physical Activity (Number of Steps/Day)Before and After CPAP Therapy in OSA Patients

Change in Physical activity (number of steps/day)before and after CPAP therapy in OSA patientsevaluated by actigraphy

Time frame: baseline and at 3 months

ArmMeasureValue (MEAN)Dispersion
Obstructive Sleep Apnea, CPAPChange in Physical Activity (Number of Steps/Day)Before and After CPAP Therapy in OSA Patients369 stepsStandard Deviation 157
Comparison: Multiple regression modelling was used to determine whether actigraphic or polysomnographic data were predictors for physical activity, independently from age and BMI, stepwise forward selection of variables was performed.p-value: <0.05Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026